uniQure (NASDAQ: QURE) has been one of the most eye-catching movers in recent sessions. The stock surged ~250% this Wednesday after reports that the company's gene therapy showed positive results in treating Huntington's disease. While the market cheered the news, the Adhishthana Principles paint a more cautious picture investors should not ignore.uniQure's Cycle So FaruniQure has had an eventful journey through its 18-phase Adhishthana cycle on the weekly charts. Now in Phase 17, it's worth revisiting how ...